Project 2 (Bers)
项目2(Bers)
基本信息
- 批准号:10006341
- 负责人:
- 金额:$ 74.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAdrenergic AgentsAdultAmericanArrhythmiaCa(2+)-Calmodulin Dependent Protein KinaseCaffeineCalciumCalcium-Sensing ReceptorsCardiac MyocytesCellsCessation of lifeChronicClinical DataClinical ResearchClosure by clampComplementComplexComputer ModelsConnexin 43CouplingDantroleneDataDiastoleDilated CardiomyopathyDrug TargetingEtiologyEventFeedbackFunctional disorderGap JunctionsGeneticGoalsHeartHeart DiseasesHeart failureHumanIndividualInheritedLinkMeasurementMechanicsModelingMusMuscle CellsMutationMyocardial dysfunctionOpticsOryctolagus cuniculusOutcomePathologicPathway interactionsPatientsPenetrancePhenotypePreventionRattusRyanodine Receptor Calcium Release ChannelSignal TransductionSodiumSourceTestingTissue ModelTissuesTranslatingUpdateValidationVariantVentricularcalmodulin-dependent protein kinase IIfamilial dilated cardiomyopathyhuman modelhuman stem cellsindium arsenideindividualized medicineinduced pluripotent stem cellinhibitor/antagonistinsightnovelnovel therapeuticsoutcome forecastprecision medicinepressurepreventprogramsranolazinestem cell modeluptakevoltage
项目摘要
Project 2 (Bers): Abstract
Project 2 focuses on understanding Na- and Ca-dependent myocyte mechanisms contributing to cardiac
dysfunction and arrhythmias in heart failure (HF). Hallmarks of Na & Ca dysfunction in HF include elevated
diastolic and late Na current (INaL), increased diastolic SR Ca leak, and Na/Ca exchange. These factors reduce
systolic and diastolic function and promote triggered arrhythmias in HF. Ca-Calmodulin dependent protein
kinase (CaMKII) is also chronically active in HF and directly promotes INaL and diastolic SR Ca leak via the
ryanodine receptor (RyR) and is a lynchpin in a newly appreciated vicious cycle where elevated INaL or SR Ca
leak (that cause arrhythmias) promote CaMKII activation to further promote higher INaL and SR Ca leak that
leads to both contractile dysfunction and arrhythmogenesis in HF. Our central aim is to test this working
hypothesis in adult failing hearts (and computer models of human hearts) and identify how breaking the vicious
cycle at different points can be functionally beneficial. Aim 1 will test in rabbit ventricular myocytes if functional
and arrhythmogenic effects of overload-induced HF can be prevented by inhibiting CaMKII, INaL or RyR. Aim 2
extends these tests to the intact rabbit heart level using optical mapping of [Ca]i and voltage Vm (where whole
heart arrhythmias are complicated by cell-cell coupling, source-sink mismatch and conduction/reentry issues).
Aim 3 will enhance and validate computational rabbit ventricular myocyte & tissue models and extend both to
human (using rabbit data from Aim 1 & 2 and incorporating patient-specific iPSC-derived myocyte and clinical
data (from Projects 1 & 3). These 3 Aims will provide valuable mechanistic insight into the vicious feedback
signaling, and how targeting INa, CaMKII or RyR may have benefits in acquired or inherited (Project 1) HF.
项目 2(Bers):摘要
项目 2 侧重于了解 Na 和 Ca 依赖性心肌细胞机制有助于心脏
心力衰竭(HF)中的功能障碍和心律失常。心力衰竭中 Na 和 Ca 功能障碍的标志包括升高
舒张期和晚期 Na 电流 (INaL)、舒张期 SR Ca 泄漏增加以及 Na/Ca 交换。这些因素减少
收缩和舒张功能并促进心力衰竭引发的心律失常。 Ca-钙调蛋白依赖性蛋白
激酶 (CaMKII) 在 HF 中也具有长期活性,并通过 INaL 和舒张期 SR Ca 渗漏直接促进
兰尼碱受体 (RyR),是新近认识到的恶性循环的关键,其中 INaL 或 SR Ca 升高
渗漏(导致心律失常)促进 CaMKII 激活,进一步促进更高的 INaL 和 SR Ca 渗漏,
导致心力衰竭的收缩功能障碍和心律失常。我们的中心目标是测试这个工作
成人衰竭心脏(以及人类心脏的计算机模型)的假设,并确定如何打破恶性循环
在不同点进行循环可能在功能上有益。目标 1 将测试兔心室肌细胞是否功能正常
抑制 CaMKII、INaL 或 RyR 可以预防过载诱发心力衰竭的心律失常效应。目标2
使用 [Ca]i 和电压 Vm 的光学映射将这些测试扩展到完整的兔心脏水平(其中整个
心律失常因细胞间耦合、源库不匹配和传导/折返问题而变得复杂。
目标 3 将增强和验证计算兔心室肌细胞和组织模型,并将两者扩展到
人类(使用来自目标 1 和 2 的兔子数据,并结合患者特异性 iPSC 衍生的肌细胞和临床
数据(来自项目 1 和 3)。这三个目标将为恶意反馈提供有价值的机制洞察
信号传导,以及靶向 INa、CaMKII 或 RyR 如何对获得性或遗传性(项目 1)心力衰竭有益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald M Bers其他文献
Channel Pore Mutation of RyR2 Cause Calcium Leak Independent of FKBP12.6-RyR2 and Calmodulin-RyR2 Affinity in R4496C/+ Knock-in Mouse
R4496C/敲入小鼠中 RyR2 的通道孔突变导致钙渗漏,与 FKBP12.6-RyR2 和钙调蛋白-RyR2 亲和力无关
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Hitoshi Uchinoumi; Ivanita Stefanon; Yi Yang; Mena Said; Xiaoqiong Dong; Rogerio Faustino; Jose L Puglisi; Ye Chen;er H Wehrens; Wayne S Chen; Takeshi Yamamoto; Yano Masafumi;Donald M Bers - 通讯作者:
Donald M Bers
Channel Pore Mutation of RyR2 Cause Calcium Leak Independent of FKBP12.6-RyR2 and Calmodulin-RyR2 Affinity in R4496C/+ Knock-in Mouse
R4496C/敲入小鼠中 RyR2 通道孔突变导致钙渗漏,与 FKBP12.6-RyR2 和钙调蛋白-RyR2 亲和力无关
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Hitoshi Uchinoumi; Ivanita Stefanon; Yi Yang; Mena Said; Xiaoqiong Dong; Rogerio Faustino; Jose L Puglisi; Ye Chen;er H Wehrens; Wayne S Chen; Takeshi Yamamoto; Yano Masafumi;Donald M Bers - 通讯作者:
Donald M Bers
Channel Pore Mutation of RyR2 Cause Calcium Leak Independent of FKBP12.6-RyR2 and Calmodulin-RyR2 Affinity in R4496C/+ Knock-in Mouse
R4496C/敲入小鼠中 RyR2 的通道孔突变导致钙渗漏,与 FKBP12.6-RyR2 和钙调蛋白-RyR2 亲和力无关
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Hitoshi Uchinoumi; Ivanita Stefanon; Yi Yang; Mena Said; Xiaoqiong Dong; Rogerio Faustino; Jose L Puglisi; Ye Chen;er H Wehrens; Wayne S Chen; Takeshi Yamamoto; Yano Masafumi;Donald M Bers - 通讯作者:
Donald M Bers
Channel Pore Mutation of RyR2 Cause Calcium Leak Independent of FKBP12.6-RyR2 and Calmodulin-RyR2 Affinity in R4496C/+ Knock-in Mouse
R4496C/敲入小鼠中 RyR2 的通道孔突变导致钙渗漏,与 FKBP12.6-RyR2 和钙调蛋白-RyR2 亲和力无关
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Hitoshi Uchinoumi; Ivanita Stefanon; Yi Yang; Mena Said; Xiaoqiong Dong; Rogerio Faustino; Jose L Puglisi; Ye Chen;er H Wehrens; Wayne S Chen; Takeshi Yamamoto; Yano Masafumi;Donald M Bers - 通讯作者:
Donald M Bers
Donald M Bers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald M Bers', 18)}}的其他基金
Systems Approach to Understanding Cardiovascular Disease and Arrhythmias - Cell diversity in the cardiovascular system, cell-autonomous and cell-cell signaling
了解心血管疾病和心律失常的系统方法 - 心血管系统中的细胞多样性、细胞自主和细胞间信号传导
- 批准号:
10386681 - 财政年份:2021
- 资助金额:
$ 74.77万 - 项目类别:
Modelling structural and functional heterogeneity in heart failure reveals arrhythmic impact
心力衰竭的结构和功能异质性建模揭示了心律失常的影响
- 批准号:
10449125 - 财政年份:2019
- 资助金额:
$ 74.77万 - 项目类别:
Modelling structural and functional heterogeneity in heart failure reveals arrhythmic impact
心力衰竭的结构和功能异质性建模揭示了心律失常的影响
- 批准号:
10199780 - 财政年份:2019
- 资助金额:
$ 74.77万 - 项目类别:
Systems Approach to Understanding Cardiac Arrhythmias Mechanisms
了解心律失常机制的系统方法
- 批准号:
9763307 - 财政年份:2019
- 资助金额:
$ 74.77万 - 项目类别:
CaMKII activation and regulation in adult cardiac myocytes
成人心肌细胞中 CaMKII 的激活和调节
- 批准号:
9905549 - 财政年份:2018
- 资助金额:
$ 74.77万 - 项目类别:
CaMKII activation and regulation in adult cardiac myocytes
成人心肌细胞中 CaMKII 的激活和调节
- 批准号:
10687251 - 财政年份:2018
- 资助金额:
$ 74.77万 - 项目类别:
相似国自然基金
记忆再巩固中去甲肾上腺素能系统在药物依赖戒断后潜伏心理渴求中的作用
- 批准号:82001404
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
肾上腺素能受体SNPs及PWV、CBP对射血分数保留心衰的发病及药物敏感性的影响
- 批准号:81471402
- 批准年份:2014
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias
RyR 激动剂部分且受控地消耗 SR 钙可预防钙依赖性心律失常
- 批准号:
10577630 - 财政年份:2023
- 资助金额:
$ 74.77万 - 项目类别:
Sympathetic neural patterns and transduction in obesity-associated hypertension
肥胖相关高血压的交感神经模式和转导
- 批准号:
10877436 - 财政年份:2023
- 资助金额:
$ 74.77万 - 项目类别:
Illuminating the function regulome of cardiac L-type Ca2+ channels in health and disease
阐明心脏 L 型 Ca2 通道在健康和疾病中的功能调节组
- 批准号:
10628916 - 财政年份:2023
- 资助金额:
$ 74.77万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 74.77万 - 项目类别:
Sympathetic neural patterns and transduction in obesity-associated hypertension
肥胖相关高血压的交感神经模式和转导
- 批准号:
10039251 - 财政年份:2020
- 资助金额:
$ 74.77万 - 项目类别: